Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera

被引:0
作者
Matsuno, H
Yudoh, K
Nakazawa, F
Sawai, T
Uzuki, M
Nishioka, K
Yonehara, S
Nakayama, J
Ohtsuki, M
Kimura, T
机构
[1] Toyama Med & Pharmaceut Univ, Dept Orthopaed Surg, Toyama 9300194, Japan
[2] Iwate Med Sch, Dept Pathol, Morioka, Iwate, Japan
[3] St Marianna Univ, Inst Med Sci, Kawasaki, Kanagawa, Japan
[4] Kyoto Univ, Inst Virus Res, Kyoto, Japan
[5] Sankyo Co Ltd, Neurosci & Immunol Res Labs, Tokyo 140, Japan
关键词
apoptosis; rheumatoid arthritis; scid mouse; treatment lymphocytes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Anti-Fas monoclonal antibodies (Mab) are considered to be a potential therapeutic agent for rheumatoid arthritis (RA). However, Fas mediated liver and chondrocyte damage is a serious problem in its clinical application. m-HFE7A, a novel anti-Fas Mab, selectively induces apoptosis in inflammatory cells. We succeeded in humanizing m-HFE7A to obtain h-HFE7A. We investigated the therapeutic effects of h-HFE7A Mab in RA. Methods. We investigated the apoptosis-inducing activities of h-HFE7A on human Fas ligand transfected cells and cultured human activated lymphocytes (human peripheral blood mononuclear cells and isolated human RA synovial lymphocytes), synoviocytes, and chondrocytes. We then examined the effects of h-HFE7A Mab in vivo using SCID-HuRAg mice implanted with human RA tissue. Results. Administration of h-HFE7A Mab alone did not induce apoptosis in cultured human Fas ligand transfected cells and activated lymphocytes. However, apoptosis-inducing activities were noted by this Mab crosslinking with a secondary antibody or Fcgamma receptor positive cells. In contrast, no apoptosis induction by h-HFE7A was observed on cultured synoviocytes and chondrocytes with or without crosslinking. Thus the crosslinking with Fcgamma receptor positive cells is essential for the efficacy of this Mab in vivo. In the implanted tissue of the SCID-HuRAg mice, the number of inflammatory cells was significantly decreased in the h-HFE7A Mab treated group compared to the IgG treated control group. Moreover, there were only negligible effects in synoviocytes and chondrocytes with the h-HFE7A Mab. Conclusion. Administration of this novel humanized anti-Fas Mab may provide a new treatment for RA by inducing Fas mediated apoptosis in inflammatory cells.
引用
收藏
页码:1609 / 1614
页数:6
相关论文
共 20 条
[1]   TREATMENT OF DEEP CARTILAGE DEFECTS IN THE KNEE WITH AUTOLOGOUS CHONDROCYTE TRANSPLANTATION [J].
BRITTBERG, M ;
LINDAHL, A ;
NILSSON, A ;
OHLSSON, C ;
ISAKSSON, O ;
PETERSON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :889-895
[2]   Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I fax transgenic mice [J].
Fujisawa, K ;
Asahara, H ;
Okamoto, K ;
Aono, H ;
Hasunuma, T ;
Kobata, T ;
Iwakura, Y ;
Yonehara, S ;
Sumida, T ;
Nishioka, K .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :271-278
[3]   Fas/Fas ligand expression and induction of apoptosis in chondrocytes [J].
Hashimoto, S ;
Setareh, M ;
Ochs, RL ;
Lotz, M .
ARTHRITIS AND RHEUMATISM, 1997, 40 (10) :1749-1755
[4]   A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity [J].
Ichikawa, K ;
Yoshida-Kato, H ;
Ohtsuki, M ;
Ohsumi, J ;
Yamaguchi, J ;
Takahashi, S ;
Tani, Y ;
Watanabe, M ;
Shiraishi, A ;
Nishioka, K ;
Yonehara, S ;
Serizawa, N .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (04) :555-562
[5]  
MAIER R, 1993, J BIOL CHEM, V268, P21527
[6]   Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs - the disulfide structure of SA96 metabolites plays a critical role in the pharmacological action of the drug [J].
Matsuno, H ;
Sugiyama, E ;
Muraguchi, A ;
Nezuka, T ;
Kubo, T ;
Matsuura, K ;
Tsuji, H .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1998, 20 (06) :295-304
[7]  
Matsuno H, 1998, ARTHRITIS RHEUM, V41, P2014, DOI 10.1002/1529-0131(199811)41:11<2014::AID-ART17>3.3.CO
[8]  
2-K
[9]  
MATSUNO H, 1999, MECH LOADING BONE JO, P215
[10]  
Morita I, 1998, INT J TISSUE REACT, V20, P37